Get the top three things to know in women's health + wellness, every weekday:

Menopause Needs More Attention, And Sometimes, Medicine

What: Dr Nadia El-Awady, the medical editor for UK Medscape, offers another take on the Lancet’s menopause edition, saying the focus on “over-medicalization” is unhelpful. “In the UK, and thanks to much-needed recent media attention, menopause is finally becoming a topic of public discussion. Women are more aware that hormone replacement therapy (HRT) is not as risky as we were led to believe in the early 2000s, and that it can, where needed, provide relief from difficult symptoms. But we are only just beginning to get easier access to HRT.”

Why it matters: She makes an excellent point – “Certainly, many women can and do manage their menopausal transition without healthcare support. …But there are many women who, no matter what amount of exercise, healthy food, and positive attitude towards ageing that they have, will still face significant challenges.”

Source: Medscape

More News Snippets
Saving the Tiniest Babies

Advances in neonatal care now make it possible to save extremely premature babies, some born as early as 22 weeks.

Medicare and Medicaid in Oz

Donald Trump has nominated Dr. Mehmet Oz to lead Medicare and Medicaid–the country’s massive health insurance programs for the elderly and lower-income adults and children.

The Birth Rate Fallacy

Experts explaining that the global drop in fertility rates is partly a product of women having children later in life.

To Prevent the Cancer from Returning

An essay from Rachel Manteuffel on her breast cancer diagnosis and treatment that manages to be funny while also tackling the wrenching choice to have chemotherapy or not after a mastectomy.

Georgia Fires Entire Maternal Mortality Committee

Georgia state officials shut down an entire committee dedicated to reviewing maternal mortality in the state, after ProPublica reported in September on the deaths of two women as a result of the state’s abortion ban.

Could Ozempic Prevent Fibroids?

Women with type 2 diabetes who got a GLP-1 medication were less likely to develop new fibroids than women who just took metformin, a diabetes medication.